Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: a 52-week Italian real-life experience

Giacomo Caldarola, Arianna Zangrilli, Gerardo Palmisano, Mauro Bavetta, Gaia Moretta, Gianluca Pagnanelli, Vincenzo Panasiti, Luca Bianchi, Clara De Simone, Ketty Peris

Article Type

Review

Published

This multicentre, retrospective study evaluates the efficacy and safety of risankizumab in a population of psoriatic patients with palmoplantar involvement over a 52-week treatment period.

Read more

Sensory properties analysis of a calcipotriol and betamethasone dipropionate cream vehicle formulated with an innovative PAD Technology for the treatment of plaque psoriasis on the skin and scalp

Nuria García, Pere Guiró, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Tiago Torres

Article Type

Original Research

Published

This study characterizes the sensorial attributes of the calcipotriol
(CAL) and betamethasone dipropionate (BDP) polyaphron dispersion cream vehicle and compares them with the sensorial attributes of conventional formulations for psoriasis such as an ointment and an oleogel product.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.